Merck Serono S.A. - Strategic Analysis ReviewSummaryMerck Serono S.A., (Merck Serono) a biotechnology company, engages in the discovery, manufacture, and marketing of therapeutic products for the treatment of human diseases, with a focus on the reproductive health, neurology, growth, and metabolism markets worldwide. The company, formerly known as Serono S.A., was founded in 1987 and changed its name to Merck Serono S.A. in January 2007. The company is headquartered in Geneva, Switzerland. It employs over 17000 people worldwide.Global Markets Direct, the leading business information provider, presents an in-depth strategic and operational analysis of Merck Serono S.A.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's views on the company.Scope-The company's strengths and weaknesses and areas of development or decline are analyzed. Strategic and operational factors are considered. -The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted. -The report contains critical company information ' business structure and operations, company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.Reasons to buy-A quick 'one-stop-shop' to understand the company. -Enhance business/sales activities by understanding customers' businesses better.-Get detailed information and strategic analysis on companies operating in your industry.-Identify prospective partners and suppliers ' with key data on their businesses and locations.-Capitalize on competitors' weaknesses and target the market opportunities available to them.-Scout for potential acquisition targets, with detailed insight into the companies' strategic and operational performance.
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
Merck Serono S.A. - Strategic Analysis Review
1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Merck Serono S.A. - Strategic Analysis Review
Published on March 2009
Report Summary
Merck Serono S.A. - Strategic Analysis Review
Summary
Merck Serono S.A., (Merck Serono) a biotechnology company, engages in the discovery, manufacture, and marketing of therapeutic
products for the treatment of human diseases, with a focus on the reproductive health, neurology, growth, and metabolism markets
worldwide. The company, formerly known as Serono S.A., was founded in 1987 and changed its name to Merck Serono S.A. in
January 2007. The company is headquartered in Geneva, Switzerland. It employs over 17000 people worldwide.
Global Markets Direct, the leading business information provider, presents an in-depth strategic and operational analysis of Merck
Serono S.A.. The report provides a comprehensive insight into the company, including business structure and operations, executive
biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's views on the
company.
Scope
-The company's strengths and weaknesses and areas of development or decline are analyzed. Strategic and operational factors are
considered.
-The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are
highlighted.
-The report contains critical company information ' business structure and operations, company history, major products and services,
key competitors, key employees and executive biographies, different locations and important subsidiaries.
Reasons to buy
-A quick 'one-stop-shop' to understand the company.
-Enhance business/sales activities by understanding customers' businesses better.
-Get detailed information and strategic analysis on companies operating in your industry.
-Identify prospective partners and suppliers ' with key data on their businesses and locations.
-Capitalize on competitors' weaknesses and target the market opportunities available to them.
-Scout for potential acquisition targets, with detailed insight into the companies' strategic and operational performance.
Table of Content
Table Of Contents
Merck Serono S.A. - Strategic Analysis Review Page 1/4
2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Key Information 1
Key Facts 1
Table Of Contents 2
List of Tables 2
Business Description 3
Major Products and Services 4
Overview 4
History 4
SWOT Analysis Overview 5
Overview 5
Merck Serono S.A. - Strengths 5
Diversified Geographic Presence 5
Broad Product portfolio 5
Focused R&D Activities 5
Merck Serono S.A. - Weaknesses 5
Wear Presence in Emerging Markets 5
Merck Serono S.A. - Opportunities 6
Diversified Therapeutic Focus 6
Changing Demographics 6
Rising Healthcare Expenditure in the US 6
Merck Serono S.A. - Threats 6
Changing Political Climate in USA 6
Tightening of FDA's Regulatory Oversight 6
Increased Pricing Control 6
Growing Parallel Trade 7
Key Competitors 8
Key Employees 8
Company Statement 9
Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Appendix 11
Methodology 11
About Global Markets Direct 11
Contact Us 11
Disclaimer 11
List of Tables
Merck Serono S.A., Key Facts 1
Merck Serono S.A., Key Facts 1
Major Products and Services 4
Merck Serono S.A., History 4
Merck Serono S.A. - Strategic Analysis Review Page 2/4
3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Merck Serono S.A. - Strategic Analysis Review
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 125.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Merck Serono S.A. - Strategic Analysis Review Page 3/4
4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Merck Serono S.A. - Strategic Analysis Review Page 4/4